ArticleBMJ open2026

Risk factors for skin rash among patients with cancer receiving epidermal growth factor receptor inhibitors: a scoping review protocol.

Lijuan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.